NPI: 1154386431 · OPELIKA, AL 36801 · General Acute Care Hospital · NPI assigned 04/19/2006
Authorized official PRICE, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | PRICE, SAMUEL (CFO) |
| NPI Enumeration Date | 04/19/2006 |
Other providers sharing the same authorized official: PRICE, SAMUEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 47,075 | $867K |
| 2019 | 49,842 | $881K |
| 2020 | 28,342 | $522K |
| 2021 | 29,846 | $629K |
| 2022 | 34,236 | $828K |
| 2023 | 42,943 | $1.39M |
| 2024 | 29,005 | $1.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 26,144 | 25,152 | $1.76M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 27,620 | 26,655 | $1.09M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 15,732 | 14,023 | $676K |
| 80053 | Comprehensive metabolic panel | 28,052 | 25,886 | $294K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,342 | 25,161 | $234K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,017 | 953 | $180K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 480 | 468 | $127K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,685 | 1,520 | $94K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3,734 | 3,452 | $91K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 328 | 318 | $90K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,201 | 673 | $85K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 3,877 | 3,544 | $84K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3,512 | 3,164 | $77K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,370 | 2,620 | $64K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,854 | 539 | $55K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,419 | 1,384 | $55K |
| 86762 | 2,765 | 2,468 | $53K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2,136 | 2,015 | $51K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,371 | 3,847 | $48K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,772 | 1,576 | $46K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,498 | 2,422 | $45K |
| 87340 | 3,377 | 3,043 | $44K | |
| G0378 | Hospital observation service, per hour | 1,514 | 1,093 | $42K |
| 80061 | Lipid panel | 2,290 | 2,253 | $39K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 717 | 682 | $35K |
| 84702 | 2,937 | 2,374 | $35K | |
| 86850 | 5,433 | 4,849 | $34K | |
| 86592 | 6,177 | 5,572 | $33K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,151 | 2,060 | $33K |
| 85027 | 7,128 | 6,207 | $32K | |
| 87536 | 1,203 | 1,161 | $32K | |
| 87070 | 2,328 | 2,095 | $26K | |
| 81003 | 8,966 | 8,600 | $24K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 134 | 110 | $24K |
| 88307 | 143 | 141 | $21K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 108 | 98 | $20K |
| 86360 | 478 | 449 | $18K | |
| 86803 | 924 | 854 | $17K | |
| 87428 | 385 | 364 | $17K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 524 | 471 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 973 | 924 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,120 | 1,050 | $15K |
| 82950 | 2,220 | 2,002 | $15K | |
| 76830 | Ultrasound, transvaginal | 480 | 458 | $14K |
| 82105 | 658 | 627 | $14K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 750 | 289 | $13K |
| 83021 | 885 | 810 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | 1,154 | 1,135 | $13K |
| 84146 | 417 | 392 | $11K | |
| 82677 | 363 | 350 | $11K | |
| 83735 | 1,353 | 1,326 | $10K | |
| 83002 | 462 | 430 | $10K | |
| 83001 | 456 | 430 | $10K | |
| 84439 | 1,012 | 965 | $10K | |
| 83020 | 531 | 469 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,061 | 1,047 | $9K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 117 | 114 | $9K |
| 86900 | 3,247 | 2,875 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,026 | 993 | $9K |
| 86901 | 3,234 | 2,863 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 377 | 346 | $7K |
| 86336 | 363 | 350 | $7K | |
| 59025 | Fetal non-stress test | 1,261 | 805 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 156 | 150 | $6K |
| 88182 | 838 | 449 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 160 | 154 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 38 | 38 | $5K |
| 87625 | 196 | 184 | $5K | |
| 85652 | 1,408 | 1,361 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 242 | 114 | $4K |
| 93976 | 47 | 46 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 32 | 32 | $4K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 18 | 18 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 105 | 63 | $4K |
| 77336 | 192 | 56 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 58 | 57 | $3K |
| 43235 | 12 | 12 | $3K | |
| 36902 | 55 | 52 | $3K | |
| 87807 | 207 | 205 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 174 | 173 | $2K |
| 83655 | 135 | 130 | $2K | |
| 71045 | Radiologic examination, chest; single view | 349 | 336 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 38 | 36 | $2K |
| 85045 | 286 | 281 | $2K | |
| 93458 | 12 | 12 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | 32 | 30 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 104 | 37 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 26 | 25 | $1K |
| 81025 | 370 | 335 | $1K | |
| 84484 | 190 | 186 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 559 | 513 | $926.81 |
| 85014 | 2,266 | 2,051 | $901.22 | |
| 85018 | 2,265 | 2,050 | $897.75 | |
| 84466 | 39 | 39 | $894.24 | |
| 82570 | 122 | 94 | $869.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,011 | 970 | $861.05 |
| 86140 | 580 | 542 | $586.95 | |
| 80069 | 97 | 84 | $586.74 | |
| 82607 | 26 | 26 | $572.01 | |
| 96367 | 19 | 12 | $567.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 939 | 739 | $541.12 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 34 | 12 | $533.50 |
| 82728 | 39 | 39 | $532.80 | |
| 95816 | 12 | 12 | $525.84 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,165 | 622 | $505.55 |
| 85041 | 1,005 | 909 | $505.38 | |
| 84156 | 106 | 81 | $497.87 | |
| 80076 | 63 | 63 | $484.88 | |
| 83615 | 61 | 55 | $440.55 | |
| 94729 | 17 | 17 | $435.96 | |
| 87088 | 54 | 38 | $429.12 | |
| 82803 | 16 | 16 | $399.42 | |
| 94726 | 17 | 17 | $398.02 | |
| 83540 | 39 | 39 | $367.20 | |
| 88300 | 184 | 184 | $355.40 | |
| 80164 | 15 | 14 | $352.94 | |
| 82140 | 14 | 14 | $317.52 | |
| 86787 | 13 | 13 | $293.52 | |
| 84460 | 33 | 24 | $281.07 | |
| 82565 | 243 | 220 | $251.86 | |
| 84450 | 33 | 24 | $248.36 | |
| 76801 | 16 | 12 | $234.53 | |
| 87186 | 39 | 24 | $222.42 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 381 | 221 | $191.05 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 32 | 12 | $182.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,017 | 918 | $145.96 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 718 | 547 | $143.84 |
| 87081 | 12 | 12 | $133.50 | |
| 82248 | 25 | 25 | $118.45 | |
| 80051 | 114 | 103 | $103.51 | |
| 82947 | 666 | 611 | $93.00 | |
| 84520 | 201 | 185 | $81.20 | |
| J1790 | Injection, droperidol, up to 5 mg | 29 | 27 | $73.80 |
| 86706 | 14 | 13 | $72.75 | |
| 82375 | 15 | 15 | $68.64 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 480 | 447 | $60.22 |
| 83690 | 13 | 12 | $56.56 | |
| 81001 | 12 | 12 | $49.12 | |
| J2704 | Injection, propofol, 10 mg | 660 | 604 | $42.40 |
| 84132 | 454 | 414 | $40.32 | |
| 84295 | 453 | 414 | $40.32 | |
| 83050 | 15 | 15 | $38.22 | |
| 85049 | 17 | 15 | $26.94 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 37 | 36 | $22.64 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 881 | 772 | $16.62 |
| J0690 | Injection, cefazolin sodium, 500 mg | 304 | 258 | $14.12 |
| J7050 | Infusion, normal saline solution, 250 cc | 33 | 24 | $12.82 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,471 | 1,089 | $12.52 |
| J1644 | Injection, heparin sodium, per 1000 units | 1,195 | 713 | $8.20 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 12 | 12 | $6.22 |
| 36415 | Collection of venous blood by venipuncture | 355 | 333 | $0.00 |
| 86361 | 637 | 625 | $0.00 | |
| 29581 | 170 | 80 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 90 | 89 | $0.00 |
| 82962 | 231 | 189 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 86 | 86 | $0.00 |
| C1769 | Guide wire | 123 | 117 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 39 | 36 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 13 | 12 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 15 | 12 | $0.00 |
| J3490 | Unclassified drugs | 51 | 26 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 26 | 25 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 124 | 117 | $0.00 |
| 99152 | 77 | 67 | $0.00 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 12 | 12 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 12 | 12 | $0.00 |